(Date:11/30/2009)... , CHANGCHUN, China and LOS ANGELES, Nov....harmaceuticals, Inc. (OTC Bulletin Board: CYXN; ,C... leading manufacturer, distributor and,retailer of...unced it has,completed preparation for distributio... The Chinese government recently formalized the...
(Date:11/30/2009)... , SEATTLE, Nov. 30 /PRNewswire-FirstCall/... CTIC) announced today that its new class of plati...tes, demonstrated a stronger anti-tumor potency an...m-based compounds as well as the ability to overco... results were presented in a paper titled "Novel B...
(Date:11/30/2009)... , AMSTERDAM, Novem...ld,s,leading publisher of scientific, medical and ... major re-launch of Embase, its comprehensive biom...d records from more than 7,000,active, peer review...ey role in the advancement of new biomedical,and p...
(Date:11/27/2009)..., PARIS, November 27 /PRNewswire-FirstCall/...l to market Oralair(R) in both adults and children...the first country where,Oralair(R) has been market...lair(R) is now registered in Austria, Belgium, Bul..., Germany, Greece, Hungary, Ireland, Italy,Latvia...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3...making sensational, not entirely accurate, extrapo...n current conditions, which is nice work if you ca...ew published an article by Carr titled IT Doesn,t ... ubiquitous and available to all who want it and t...ve advantage. , ,Even discounting that sustainable...
...aped January a notoriously depressing month becau...and dank weather thats no surprise. In fact, an E...st one week ago) was the most depressing day of th...bear an extra psychological burden because of the ...escalated last month for reasons that have nothing...
...sentation times at the Midwest Venture Summit on M...sociation (IVCA) will be selecting only a handful... investors and venture capitalists. , ,Applicants ...been chosen by the IVCA. The panel will consider t...eloping, as well as its finances, expenses, manage...
Other Biology Technology:Whining should not get in the way of innovation 2Whining should not get in the way of innovation 3Post-January, tech entrepreneurs have reasons to be depressed 2Post-January, tech entrepreneurs have reasons to be depressed 3Post-January, tech entrepreneurs have reasons to be depressed 4Follow the money 2Follow the money 3Chloramphenicol Acetyltransferase Fluorometric (BODIPY) Assay Kit, FAST CAT from Molecular Probes (Invitrogen)
Polyethylene Glycol 8000 from GE Healthcare, formerly Amersham Biosciences
Panomer 9 random oligodeoxynucleotide, Alexa Fluor 647 conjugate from Molecular Probes (Invitrogen)
GIBCO Chicken Serum from Invitrogen
Biology Products: